BioNTech SE (BNTX) Enterprise Value (2019 - 2026)
BioNTech SE's Enterprise Value came in at $11.33 billion for Q3 2026, down 51.1% from $23.17 billion a year earlier but up 12.0% from the prior quarter.
Powered by 
Analysis
BioNTech SE (BNTX) Enterprise Value (2019 - 2026) Analysis & Trends
Over the trailing twelve months to Sep 30, 2026, BioNTech SE reported Enterprise Value of -$34.65 billion; for FY2025, it came in at $5.51 billion, down 34.0% from FY2024.
- Enterprise Value has declined in each of the last four years, with a five-year compound annual growth rate of -20.7% (FY2020 to FY2025).
- Going back by year, Enterprise Value was $8.36 billion in FY2024 (-50.4%), $16.85 billion in FY2023 (-20.6%), $21.21 billion in FY2022 (-55.1%) and $47.26 billion in FY2021 (+169.5%).
- The five-year range for quarterly Enterprise Value is $5.51 billion (Q4 2025) to $47.26 billion (Q4 2021).
- Year-over-year, Enterprise Value has declined for four consecutive quarters, with growth averaging 27.5% over the last eight quarters.
- The fastest year-over-year change in Enterprise Value over five years came in Q2 2025 (growth of 290.9%), and the weakest in Q3 2022 (a decline of 68.6%).
- Business Quant data shows BNTX's Enterprise Value at $10.11 billion (Q2 2026), $8.47 billion (Q1 2026) and $5.51 billion (Q4 2025) in the three quarters before Q3 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn |
| 10 | BioNTech SE | 21.19 Bn | -49.68 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 11.33 Bn |
| Jun 30, 2026 | 10.11 Bn |
| Mar 31, 2026 | 8.47 Bn |
| Dec 31, 2025 | 5.51 Bn |
| Sep 30, 2025 | 23.17 Bn |
| Jun 30, 2025 | 25.43 Bn |
| Mar 31, 2025 | 16.25 Bn |
| Dec 31, 2024 | 8.36 Bn |
| Sep 30, 2024 | 16.00 Bn |
| Jun 30, 2024 | 6.51 Bn |
| Mar 31, 2024 | 10.53 Bn |
| Dec 31, 2023 | 6.77 Bn |
| Sep 30, 2023 | 10.56 Bn |
| Jun 30, 2023 | 9.12 Bn |
| Mar 31, 2023 | 16.21 Bn |
| Dec 31, 2022 | 21.21 Bn |
| Sep 30, 2022 | 20.04 Bn |
| Jun 30, 2022 | 26.99 Bn |
| Mar 31, 2022 | 35.16 Bn |
| Dec 31, 2021 | 47.26 Bn |
API Access
BioNTech SE Enterprise Value API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=enterprise-value&ticker=BNTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "enterprise-value", "ticker": "BNTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=enterprise-value&ticker=BNTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();